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Abstract  
Paracrine signalling mediated via cytokine secretion is essential for liver regeneration 
after hepatic resection, yet the mechanisms of cellular crosstalk between immune 
and parenchymal cells are still elusive. Interleukin-22 (IL-22) is released by immune 
cells and mediates strong hepatoprotective functions. However, it remains unclear if 
IL-22 is critical for the crosstalk between liver lymphocytes and parenchymal cells 
during liver regeneration after partial hepatectomy. Here we found that plasma levels 
of IL-22 and its upstream cytokine IL-23 are highly elevated in patients after major 
liver resection. In a mouse model of partial hepatectomy, deletion of IL-22 was 
associated with significantly delayed hepatocellular proliferation and an increase of 
hepatocellular injury and endoplasmic reticulum stress. Using Rag1-/- and Rag2-/-γc-/- 
mice we show that the main producers of IL-22 post partial hepatectomy are 
conventional natural killer cells and innate lymphoid cells type 1. Extracellular ATP, a 
potent danger molecule, is elevated in patients immediately after major liver 
resection. Antagonism of the P2 type nucleotide receptors P2X1 and P2Y6 
significantly decreased IL-22 secretion ex vivo. In vivo, specific inhibition of P2X1 
was associated with decreased IL-22 secretion, elevated liver injury and impaired 
liver regeneration. Conclusion: This study shows that innate immune cell derived IL-
22 is required for efficient liver regeneration and that the secretion of IL-22 in the 
regenerating liver is modulated by the ATP receptor P2X1. 
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Cellular crosstalk including secretion of cytokines and paracrine signaling via danger-
associated molecular patterns is essential for liver regeneration after hepatic 
resection. The cytokine IL-22 is released by immune cells and acts primarily on 
nonhematopoietic cells such as epithelial cells unlike most other cytokines, which 
target hematopoietic cells (1). In the liver IL-22 acts on hepatocytes and stellate cells 
and exhibits hepatoprotective properties by reducing liver fibrosis and ameliorating 
acute liver injury (2-5). In response to partial hepatectomy levels of IL-22 are elevated 
in the regenerating liver and exogenous administration of IL-22 as well as transgenic 
expression is associated with improved outcome (5). Yet it remains unclear what the 
source and triggering factors of IL-22 in response to partial hepatectomy are and 
whether IL-22 is essential for liver regeneration.  
 
We hypothesize that IL-22 is an unidirectional and critical mediator between specific 
immune cells and hepatocytes that mediates hepatoprotection. In this study, we 
aimed to identify the source and the role of IL-22 in liver regeneration after partial 
hepatectomy.  
 
Various sources of IL-22 have been described including γδ T cell, natural killer T cells 
(NKT), natural killer (NK) cells, Th17 cells and non-NK cell subsets of innate 
lymphoid cells (ILC), of which the first three cell types have been described to impact 
on liver regeneration (1, 6-8). Interestingly, the role of ILC in the context of liver 
regeneration remains unexplored. ILC is a collective term for innate lymphocytes that 
lack a specific antigen receptor yet can produce an array of effector cytokines that 
exhibit functions such as tissue remodeling, antimicrobial immunity and inflammation 
(9). ILC are further subdivided into at least three groups ILC1-3 according to 
transcription factors and secreted cytokines (10). Most recently, cytokine producing 
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ILC1 within the liver are now distinguished from conventional NK cells (cNK; that are 
also considered as killer ILC) by the presence of the integrin subunit CD49a (11, 12). 
In the light of such new diversity of innate immune cells, one specific aim of our 
studies was to identify the cellular subtype that secretes IL-22 in the liver and how 
this secretion is being regulated. 
 
The nucleotide adenosine triphosphate (ATP) is released at early time points after 
partial hepatectomy (8, 13). Extracellular nucleotides modulate cellular injury, 
proliferation and crosstalk (8, 14-16) via specific purinergic P2Y (G-protein coupled) 
and P2X (ligand-gated ion channel) receptors. Purinergic receptors are expressed on 
many cell types including intrahepatic lymphocytes of which cNK, NKT and ILC1 
represent the largest fraction (17, 18). However, the cellular and molecular 
mechanisms downstream of extracellular nucleotides receptors that promote liver 
regeneration are still unclear. Based on our previous studies we hypothesized that 
purinergic signaling modulates other effector functions of hepatic immune cells 
including IL-22 secretion (8, 19, 20).  
 
Here we show that IL-22 is secreted after partial hepatectomy by the ILC subsets 
cNK cells and ILC1 in the human and rodent liver and that IL-22 is required for 
efficient liver regeneration. This IL-22 production is modulated by extracellular ATP 
via P2X1 receptors.  
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Materials and Methods 
 
Serum samples from patients 
Plasma samples of patients undergoing liver resection were collected at the 
department of surgery at the medical University of Vienna, Austria. Only major 
resections according to the IHPBA Brisbane 2000 nomenclature (< 3 segments = 
minor, ≥ 3 segments = major) (21) were included. Samples for cytokine analysis were 
collected from 40 patients preoperatively and 5 days postoperatively between 
February 2012 and June 2014 within a prospective observational trial 
(ClinicalTrials.gov Identifier: NCT01700231). Groups are illustrated in supplementary 
table 1. Intraoperative samples for ATP measurements were collected from 27 
patients between January 2013 and January 2015 (ClinicalTrials.gov Identifier: 
NCT02113059). Groups are illustrated in supplementary table 2. The evaluation of 
blood samples and patient data was approved by the Institutional Ethics Committee 
of Vienna (#424/2010 and #2032/2013) all patients gave written informed consent.  
 
Definition and Classification of Postoperative Liver Dysfunction and Morbidity  
The criteria issued by the International Study Group of Liver Surgery (ISGLS) were 
applied to evaluate liver dysfunction i.e. post-hepatectomy liver failure (22). 
Accordingly, liver dysfunction was defined by an abnormal serum bilirubin (SB) level 
and prothrombin time (PT) on or after postoperative day (POD) 5 based on the 
threshold values of the local laboratory: >1.2 mg/dl serum bilirubin (SB) and <75% 
prothrombin time (PT). Patients with an abnormal preoperative SB or PT, a 
postoperative aggravation on or after POD 5 (compared to the previous day) were 
defined as postoperative liver dysfunction. In patients with normal SB or PT values 
prior to POD 5 and discharged early due to good clinical performance, no further 
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blood collection could be performed on or after POD 5. These patients were 
considered as “no post-hepatectomy liver failure”. To evaluate postoperative 
morbidity, the severity of postoperative complications was recorded in grade I to V. 
 
Mice and surgical procedures 
Animals were housed in specific pathogen free (SPF) conditions in accordance with 
Swiss veterinary office. All animals used for the experiments were on C57Bl/6 
background with an age of 8 to 12 weeks and were males. C57Bl/6 wild type (WT) 
animals were purchased from Harlan, Netherlands. CD39-/- mice were provided by 
Simon Robson (Beth Israel Deaconess Medical Center, Boston) and IL-22-/- mice 
were provided by Jean-Christophe Renauld (Ludwig Institute for Cancer Research, 
Catholic University of Louvain, Brussels, Belgium). Rag1-/- animals housed in altered 
Schaedler’s flora (ASF) were purchased from clean mouse facility, University of Bern. 
Rag2-/-γc-/- mice were purchased from Taconic (Germantown NY). For 70% partial 
hepatectomy, animals were anaesthetized using isoflurane followed by ligation and 
resection of median and left liver lobes as described previously (23).  All protocols 
were approved by Bernese cantonal authorities. 
 
Flow cytometry 
Lymphocytes isolated from different organs were analyzed using flow cytometer by 
staining with cells with monoclonal antibodies (mAbs) according to the manufacturers 
protocols. Following fluorescently labeled human mAbs were used: CD3 (HIT3a), 
CD56 (HCD56), NKP46 (P44-8), CD4 (OKT4), TCRγδ (B1) and mouse mAbs CD3e 
(17A2), NK1.1 (PK136), NKp46 (29A1.4), CD4 (GK1.5), CD19 (6D5), TCRγδ (GL3), 
CD127 (A7R34), CD117 (2B8), CD49b (DX5) (Biolegend) and CD39 (24MDS1) 
(eBioscience), CD49a (Ha31/8) (BD, Biosciences). For intracellular staining of IL-22, 
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freshly isolated lymphocytes were incubated for 5 hours with IL-23 (10ng/ml, 
Peprotech) and Brefeldin A (10µg/ml) (Sigma) in DMEM-Glutamax (life technologies), 
10% fetal bovine serum, 1% penicillin/streptomycin, 0.7% β-mercaptoethanol (sigma) 
and 1% Hepes (GIBCO). After five hours cells were fixed by fixation/permeabilization 
buffer (eBioscience) and stained for intracellular IL-22 (mAbs 1H8PWSR), IL-22 
(hAbs-22URT1) (eBioscience)  and intranuclear RORγt (mAbs B2D) (BDBiosciences) 
according to the manufacturers protocol. Finally cell data were acquired on a SORP 
LSRII (BD Pharmingen). Flow cytometric analysis was done using FlowJo (Treestar). 
 
Enzyme-linked immunosorbent assay/Cytokine bead array  
Serum collected over a time course following partial hepatectomy and supernatants  
from ex vivo stimulated lymphocytes with α-CD3 ((10µg/ml) mouse (145-2C11), 
human (HIT3a) Biolegend), α-CD28 ((5µg/ml) mouse (3751), human (CD28.2), 
Biolegend),  hIL-23 (10ng/ml, Peprotech), IL-12 (10ng/ml, Peprotech)  and IL-18 
((10ng/ml), human(B001-5), mouse(B002-5), MBL) were used for measuring IL-22 
levels using ELISA kit Ready-Set-Go (eBioscience) according to the manufacturers 
protocol using a Tecan Infinite 200 plate reader (Tecan).  
Patient’s samples: The cytokines IL-1 beta EXP010-10224-901 IL-17A (EPX010-
12017-901), IL-18 (EPX010-10267-901) IL-22 (EPX010-12047-901) and IL-23 
(EPX010-12023-901) in the human plasma samples were analyzed by ProcartaPlex 
multiplex Immunoassay according to the manufacturer’s protocols (EBioscience) 
using Luminex instrument (xMAP Technology). Levels of human TGFβ were 
measured by ELISA according to the manufacturer’s protocol (88-8350-22, 
eBioscience).  
Following purinergic agonists and antagonists were used: Adenosine (Sigma), 2-
chloroadenosine (Adenosine receptor agonist), DPCPX and ZM241385 (Adenosine 
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receptor antagonist), NF449 (P2X1 antagonist), NF110 (P2X3 antagonist), 5BDBD 
(P2X4 antagonist), A804598 (P2X7 antagonist), MRS2500 or MRS2279 
(P2Y1antagonist), ARC-118925XX (P2Y2 antagonist), MRS2578 (P2Y6 antagonist), 
NF157 (P2Y11/P2X1 antagonist), Plavix (P2Y12 antagonist), MRS2211 (P2Y13 
antagonist) were purchased from Tocris.  
 
Measurement of liver injury 
Serum samples post partial hepatectomy were collected to assess the extent of liver 
injury using aspartate aminotransferase (AST) and alanine transaminase assay 
(Modular Analytics EVO, P800; Roche, Germany). 
 
Measurement of ATP levels from patients 
ATP levels in plasma samples from patients were measured by luciferin- luciferase 
bioluminescence assay according to the manufacturers protocol (Bio-Thema. 
Sweden) using a Tecan Infinite 200 plate reader (Tecan). 
 
Gene expression analysis 
Primers used were: ccnb1- (Mm03053893_gH), p21 (Mm00495793_m1), Foxm1 
(Mm00514924_m1), BIRC5 (Mm00599749_m1), TBP (Mm01277042_m1) and IL-
22ra1 (Mm01192943_m1) (Applied Biosystems) with ABI PRISM 7900 (Applied 
Biosystems). Primer for P2X1 receptor (For. 5’ CCGAAGCCTTGCTGAGAA 3’, Rev. 
3’ GGTTTGCAGTGCCGTACA T 5’ (amplicon length 87bp)),18S 
(5’GTAACCCGTTGAACCCCATT 3’, Rev. 3’ CATCCAATCGGTAGTAGCG 5’ 
(amplicon length 148bp)), IL-22 receptor expression in human liver tissue (For. 5’ 
GATCTGCTCCAGCACGTGAA, Rev.3’ GGCTTGAGGGTAGTGTGCT5’ (amplicon 
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length 302bp)) and 18S (For.5’ GTAACCCGTTGAACCCCATT3’, Rev.3’ 
CCATCCAATCGGTAGTAGCG 5’ (Amplicon length 148bp)) 
   
Immunohistochemistry 
Hepatic proliferation was assessed by Ki67 (DAKO) and PCNA (DAKO) 
immunostaining as described previously (8). Endoplasmic stress was assessed by 
using BIP/GRP78 immunofluorescence staining as described before (24). In brief 
paraffin embedded liver tissues sections were washed followed by incubating with 
3% H2O2 (Dr. Grogg; K45052100 407) in phosphate buffered saline with tween 20 
(PBS-T). After protein blocking (PBS, 3%BSA; 5%Donkey Serum; 0,1% Triton-X-100) 
the slides were incubated with primary rabbit Anti-GRP78/BIP (Abcam; ab21685, 
1:500) antibody in the protein block over night at 4 °C, followed by incubation for 2h 
with donkey anti-Rabbit IgG secondary antibody conjugated with Alexa Fluor 488 
(Life Technologies; A-21206). Liver sections were stained with hematoxylin (MERK; 
HX43078349) for 1 min followed by Eosin (Fluka; 45240) staining for 6 min, later 
sections were mounted with Eukitt (Kindler, GmbH).  
 
Western blot analysis 
Proteins from the liver tissues was extracted using RIPA buffer. Proteins extracted 
were quantified using BCA kit (ThermoFischer scientific). Protein samples boiled in 
Laemmli buffer were separated by SDS-PAGE (Bio-Rad). Separated proteins were 
transferred on to polyvinyl difluoride (PVDF) membrane followed by incubation with 
the primary antibodies, overnight at 4 °C. Primary antibodies diluted in either milk or 
BSA rabbit Anti-GRP78/BIP (Abcam; ab21685, 1:2000) rabbit anti-Phospho-eIF2α 
(Ser51) (1:2000, Cell signaling. #9721) and rabbit anti-GAPDH (1:10,000, Acris, 
ACR001P). Membranes were then washed and incubated with goat-Anti-Rabbit IgG-
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HRP secondary antibody (1:10,000, Santa Cruz Biotechnology: sc-2030) for 2 hours. 
The immunoblots were then washed and developed using chemiluminescence 
(Luminata crescendo, Millipore, WBLUR0100) and for semi quantitative analysis Aida 
2d densitometry software version 3.11 was used and signal intensities were 
normalized to GAPDH.   
 
Statistical Analysis 
Statistical tests as indicated were performed with Prism software (Graph Pad 
Software). Statistically significant data are presented as follows. *p < 0.05; ** p < 
0.01; *** p < 0.001; and **** p < 0.0001. Tests are specifically indicated. 
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Results 
IL-22 is elevated in patients that underwent liver resection. In order to identify 
cytokines that mediate responses by innate immune cells and potentially contribute to 
liver regeneration, plasma samples of patients undergoing major liver resection were 
analyzed. Patient’s characteristics are illustrated in supplementary table 1. When we 
compared preoperative cytokine levels to the fifth postoperative day, we found that 
plasma levels of IL-22 were consistently increased, whereas no changes for IL-17a 
were observed (Fig. 1A, B). Cytokines that are upstream of IL-22 secretion such as 
IL-1β and IL-23 were significantly elevated after liver resection but IL-18 and TGFβ 
levels were not elevated (Fig. 1C-F) (1). In order to determine if the elevation of IL-22 
is specific in the regenerating liver, we measured IL-22 levels in patients that 
underwent major pancreatic surgery. In these patients no significant difference in IL-
22 levels was observed (Suppl. fig 1A). These findings in humans confirm studies 
performed in mice, in which levels of IL-22 are elevated in the regenerating liver 
following partial hepatectomy (5). 
 
Hepatocellular proliferation in response to partial hepatectomy is delayed in 
the absence of IL-22. In order to test the functional relevance of IL-22 in the 
regenerating liver, partial hepatectomy was performed in IL-22-/- mice and compared 
to WT mice. Liver regeneration as assessed by Ki67 and PCNA staining was 
significantly delayed in IL-22-/- mice (Fig. 2A, B) and liver weights at postoperative 
day are decreased in IL-22-/- mice compared to WT mice (Suppl. fig. 2A). In parallel, 
IL-22 receptor is upregulated in the regenerating liver (Suppl. fig. 2B,C). At 48 hours 
post partial hepatectomy, positive cell cycle regulators (Cyclin b1; Foxm1) were down 
regulated, whereas a negative cell cycle regulator (p21) is increased in partially 
hepatectomized IL-22-/- mice compared with WT mice (Fig. 2C). Moreover, 
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expression of Survivin/Birc5 that is required for hepatocellular proliferation post 
partial hepatectomy (25) was decreased in IL-22-/- mice. Thus, liver regeneration is 
decreased in IL-22-/- mice compared to WT controls.  
 
Elevated liver injury and endoplasmatic reticulum stress in IL-22-/- mice. Liver 
injury as assessed by analysis of AST and ALT  and by histology was significantly 
increased in IL-22-/- mice after partial hepatectomy compared to WT controls (Fig. 3 
A, B, Suppl. fig. 2D). Recent studies showed an association of IL-22 administration 
with reduced cellular endoplasmic reticulum (ER) stress (26). Therefore, we 
assessed levels of ER stress in the regenerating liver by staining for BiP/Grp78 and 
its down stream protein phospho-eIF2α (P-eIF2α) (Fig. 3C-E). Hepatocellular ER 
stress was slightly elevated at baseline and significantly increased after partial 
hepatectomy in IL-22-/- mice compared with WT mice.  
 
IL-22 in the regenerating liver is secreted by innate lymphoid cell subsets. IL-22 
is primarily secreted by lymphatic cells (10). To identify the cellular source of IL-22 in 
the liver under homeostatic conditions, hepatic lymphocytes were isolated from 
patients and stimulated ex vivo with IL-23. We found that CD56dimCD3- NK cells were 
the main producers of intracellular (Fig. 4A) and secreted (Fig. 4B) IL-22 in the 
human liver. In the mouse, hepatic IL-22 producing cells also include NKT and γδ T 
cells in addition to ILC1, cNK (Suppl. fig. 3A, B). In order to further determine the 
source of IL-22 during liver regeneration, two third partial hepatectomy was 
performed in WT, Rag1-/- mice (lacking T and B cells) and Rag2-/-γc-/- mice (lacking T, 
B, cNK cells and ILC) (27). Compared to WT mice, IL-22 secretion 48 hours after 
partial hepatectomy was increased in Rag1-/- mice but was absent in Rag2-/-γc-/- (Fig. 
4C, Suppl. fig.4A). Thus, cNK cells and ILC1 are the main producers of IL-22 in WT 
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and Rag1-/- mice. The fraction of ILCs in Rag1-/- mice is higher percentage compared 
to WT mice that may explain the increase of IL-22 levels (Suppl. fig. 4B). Such 
decreased systemic levels of IL-22 in Rag2-/-γc-/- mice after partial hepatectomy 
correlated with elevated liver injury (Fig. 4D, Suppl. fig. 4C, D). Furthermore, liver 
regeneration is also delayed in these mice as shown previously (8). ILCs have been 
recently classified into the three populations ILC1, ILC2 and ILC3 according to 
activating and effector cytokines as well as associated transcription factors (10). 
However, subpopulations of ILC within the liver remain largely unexplored. In the 
rodent liver we observed mainly CD49a+ and CD49b+ subsets of NK1.1+CD3- cells 
which represent classical ILC1 (CD49a+NK1.1+CD3-) and cNK (CD49b+NK1.1+CD3-) 
cells that represent a subgroup of ILCs. In addition we show only small fractions of 
ILC2 and RORγt positive ILC3 in the liver (Suppl. fig. 5A). CD49a+NK1.1+CD3-  cells 
are resident in the hepatic sinusoids and bone marrow and correspond to ILC1 (12). 
These cells, however, are found only at very low levels in other lymphoid organs. 
Conversely CD49b+NK1.1+CD3-  cells correspond to circulating and primarily 
cytotoxic cNK cells (11, 12). In the regenerating liver we observed a strong shift of 
ILC fractions with increased levels of CD49a+NK1.1+CD3- (ILC1) cells and reduced 
CD49b+NK1.1+CD3- (cNK) cells after partial hepatectomy (Fig. 4E). Together, these 
data suggest that IL-22 is secreted by ILC1 and cNK cells after partial hepatectomy.  
 
Extracellular nucleotides modulate IL-22 secretion via P2 receptors. We next 
investigated soluble factors released after partial liver hepatectomy, which may 
promote IL-22 secretion by focusing on extracellular nucleotides. Experiments in 
rodents revealed that the release of extracellular nucleotides is an early event 
following partial hepatectomy and impacts on various immune functions via the 
activation or inhibition of P2-type receptors (8, 13, 14, 20). To validate these findings 
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in humans, samples were obtained from patients undergoing major liver surgery. 
Levels of extracellular nucleotides were measured in different venous compartments 
prior to and after liver resection. Patient’s characteristics are shown in supplementary 
table 2. Extracellular ATP levels significantly increased immediately after liver 
resection in the portal and hepatic vein compared to the vena cava (Fig. 5A). To 
determine an association of extracellular ATP levels and clinical outcome, patients 
with post hepatectomy liver failure as assessed by the ISLGS (international Study 
Group of Liver Surgery) score were compared to patients without postoperative liver 
failure. Interestingly, clinical outcome significantly correlates with intraoperative ATP 
levels in the serum (Fig. 5B). Levels of extracellular ATP in the hepatic vein of 
patients with post hepatectomy liver failure were significantly lower compared to 
patients without post hepatectomy liver failure. These results show that the release of 
extracellular ATP occurs immediately in response to major liver resection and 
potentially is associated with patient’s outcome. 
 
Next we aimed to determine whether altered P2 receptor activation effects IL-22 
secretion. Analysis of gene expression data in GEO database (GEO accession 
number GSE43339) revealed that various P2 receptors are expressed in mouse cNK  
and ILC1 (Suppl. fig 6A). In order to test the functional relevance of P2 receptors on 
IL-22 secretion we induced IL-22 secretion by primary hepatic and splenic 
lymphocytes using cytokines (anti-CD3, anti-CD28, IL-12, IL-18 and IL-23) with and 
without suramin, a non-selective P2 receptor antagonist. Secretion of IL-22 was 
significantly decreased in response to suramin in hepatic and splenic lymphocytes 
(Fig. 6A, Suppl. fig. 6B). No impact on adenosine signaling was observed (Fig. 6B, 
Suppl. fig. 7A-C). In order to identify the specific P2 receptor controlling IL-22 
secretion, a screen was performed using various P2X and P2Y receptor antagonists 
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in naive WT splenic lymphocytes stimulated ex vivo. We identified significant 
reduction of IL-22 secretion in response to highly selective antagonists of the 
receptors P2X1 and P2Y6 and to a lesser extent to antagonists of P2X4, P2Y1 and 
P2Y13 in a dose dependent manner (Fig. 6C, D). In order to test whether altered 
activation or desensitization of P2-type receptors modulates IL-22 secretion, we 
assessed IL-22 secretion in mice deficient of NTPDase1/CD39, the major 
ectonucleotidase that hydrolyses ATP to AMP, which is expressed in various subsets 
of hepatic lymphocytes including ILC (Suppl. fig.8A). Secretion of IL-22 ex vivo was 
significantly decreased in hepatic lymphocytes and splenocytes isolated from CD39-/- 
mice compared to WT mice (Fig. 6E, Suppl. fig. 8B-E). In vivo, IL-22 levels in CD39-/- 
mice were significantly decreased and liver injury was increased as assesed by AST 
and ALT levels and by Hematoxilin and Eosin staining post partial hepatectomy 
compared to WT controls (Fig. 6F, Suppl. fig. 9A, B). Thus, these results show that 
disordered purinergic signaling modulates IL-22 secretion in vitro and in vivo. 
 
Liver regeneration post partial hepatectomy is impaired in response to P2X1 
inhibition. To identify whether P2 receptor signaling modulates IL-22 secretion in 
vivo and if this receptor is relevant in the regenerating liver, partial hepatectomy was 
performed in WT mice with and without P2X1 and P2Y6 receptor antagonists. In vivo, 
IL-22 levels were significantly decreased post partial hepatectomy in response to 
P2X1 receptor inhibition using a highly specific antagonist (NF449) (Fig. 7A) but not 
in response to a specific P2Y6 antagonist (MRS2578) (Fig. 7B). P2X1 receptor is 
expressed in hepatic NK, ILC1, NKT, CD4, CD8 and gamma delta T cells that are 
cellular fractions that typically secrete IL-22 (Suppl. fig. 10A). Liver proliferation as 
assessed by Ki67 and PCNA staining was not impaired in response to P2Y6 
inhibition (Fig. 7C), but significantly decreased in response to P2X1 antagonism (Fig. 
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7D, E). Liver injury is increased in response to P2X1 antagonism but not with P2Y6 
antagonism (Fig. 7F, Suppl. fig. 9B, 10B, C). Together, these data reveal that 
inhibition of P2X1 decreases IL-22 secretion and is associated with impaired liver 
regeneration post partial hepatectomy.   
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Discussion 
In this study we identified that the secretion of IL-22 by hepatic ILC subsets is 
required for efficient liver regeneration and is modulated by extracellular ATP mainly 
via the receptor P2X1. The hepatoprotective properties of IL-22 have been well 
established in models of liver injury (4, 6, 28, 29). Moreover, artificially elevated IL-22 
in transgenic mice or via exogenous administration enhances hepatocellular 
proliferation (2, 29-31). Our current study now reveals that constitutive IL-22 
secretion is required for optimal liver regeneration and its secretion is mediated via 
hepatic ILC subsets, mainly cNK cells and ILC1. The absence of these cell types in 
Rag2-/-γc-/- mice is associated with abrogated IL-22 production that explains at least in 
part impaired liver regeneration and elevated liver injury after partial hepatectomy in 
these mice (8). In other models such as drug induced liver injury, cells of the adaptive 
immune system (mainly Th22 cells) are important sources of IL-22 (31). Thus, the 
source of IL-22 depends on the context of injury.  
 
As a potential mechanism of IL-22 secretion on liver regeneration we observed 
increased ER stress in the regenerating liver of IL-22-/- mice. It is interesting to note 
that IL-22-/- livers have elevated ER stress responses already at basal level as 
observed by BiP staining and phospho-eIF2a Western blot. Thus, IL-22 seems to be 
required to achieve homeostatic balance. In a recent study, using hepatocyte-specific 
deletion of IRE1α (one branch of the ER stress response pathway), impaired liver 
regeneration after partial hepatectomy was described (32). Therefore, some ER 
stress after partial hepatectomy is required as an adaptive response. However, ER 
stress seems to be counterproductive at high, potentially excessive levels as 
observed in the IL-22-/- mice.   
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We next investigated the impact of extracellular nucleotides on IL-22 secretion in the 
regenerating liver. By showing elevated ATP levels after major liver resection we 
support previous findings in which elevation of extracellular ATP levels has been 
observed after living liver donation (13). Further we provide clinical evidence for data 
obtained in mice and rats that revealed an early increase of extracellular ATP levels 
after partial hepatectomy (8, 13). However, we found that extracellular ATP levels 
were not only increased in the hepatic venous blood but also in the portal blood. In a 
previous study in which extracellular ATP was found to be only elevated downstream 
of the liver, we measured ATP levels at the end of the operation and not immediately 
after portal clamping. Thus, extracellular ATP may be not only derived from the liver 
but potentially also from the systemic circulation in patients undergoing major 
surgery. Extracellular nucleotides exhibit pleiotropic effects on parenchymal and non-
parenchymal cell types such as resident or circulating immune cells via P2-type 
receptors (17). We found that the ATP receptor P2X1 and the UDP receptor P2Y6 
modulate IL-22 secretion in vitro. However, only antagonism of P2X1 in vivo showed 
an impact on liver regeneration.  Administration of P2Y6 antagonists was associated 
with elevated mortality after partial hepatectomy (not shown), potentially because of 
known effects on glucose metabolism (33). The results of this study suggest that ATP 
modulates the activation of lymphocytes, in particular cNK and ILC1 in the 
regenerating liver via P2X1 receptor. P2X1 is mainly expressed on circulating 
immune and inflammatory cells but not on parenchymal cells (34, 35). This pattern of 
expression parallels sources of IL-22. Thus, modulation of P2X1 has mainly indirect 
effects via the activation of circulating but not parenchymal cells. This finding is 
supported by recent studies that have shown the relevance of P2X1 in other models 
of inflammation and injury such as neutrophil migration during endotoxemia (36, 37). 
Desensitization is an inherent property of P2X1 receptor (38) and explains decreased 
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secretion of IL-22 ex vivo and in vivo in the absence of CD39 on liver lymphocytes 
(39). Thus, regulated activation of P2X1 is required for optimal secretion of IL-22.  
 
Future studies need to establish whether pharmacological strategies that alter IL-22 
levels in the postoperative period may improve the clinical outcome in patients 
undergoing major liver resection or full or partial liver transplantation. In light of the 
present study, targeting of IL-22 levels seems to be possible in several ways, first by 
direct administration of recombinant proteins, second via the modulation of P2 
receptor signaling by direct activation of P2X1 or third, indirect modulation via 
ectonucleotidases such as CD39.  
 
This study reveals the interaction of “danger signals” such as extracellular ATP, 
hepatoprotective cytokines and tissue regeneration. ATP-dependent modulation of 
the unidirectional crosstalk between liver infiltrating lymphocytes and hepatocytes via 
IL-22 may represent an evolutionarily ancient pathway initiating repair and 
regeneration.  
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Legends 
Figure 1. Increased levels of IL-22 in patients after major liver resection. 
Analysis of cytokine levels in plasma samples from patients (n=40) five days after 
major liver resection. (A, B) IL-22 but not IL-17a is elevated after resection. (C-F) 
Upstream cytokines IL-23 and IL-1beta that stimulate IL-22 secretion are significantly 
elevated post liver resection, while IL-18 and TGFβ are not elevated. Each data point 
represents an individual patient, the line represents the mean (t-test). 
 
Figure 2. IL-22 is required for optimal hepatocellular proliferation post liver 
resection. Liver regeneration was assessed in a mouse model of partial 
hepatectomy using IL-22-/-  and WT mice (n=5 per time point). (A, B) Hepatocellular 
proliferation was assessed by using Ki67 and PCNA staining (counts of Ki67 or 
PCNA positive cells per high-power field (HPF) with a magnification of 40x). Each 
data point represents a single mouse, the line represents the mean. Percentages of 
Ki67 and PCNA positive cells were lower in IL-22-/- mice at early time points post 
partial hepatectomy compared to WT. (C) Positive cell cycle regulators (Cyclin 1; 
Foxm1) were down regulated whereas negative cell cycle regulators (p21) were 
increased in IL-22-/- mice compared to WT mice. Survivin (Birc5) an anti-apoptotic 
gene is down regulated in IL-22-/- mice (t-test).   
 
Figure 3. Elevated liver injury and endoplasmic reticulum (ER) stress in IL-22-/- 
livers post partial hepatectomy. (A, B) Hepatocellular injury was assessed by 
aspartate aminotransferase (AST) and alanine transaminase (ALT) levels post partial 
hepatectomy in IL-22-/- mice and compared to WT mice. Each data point represents a 
single mouse, the line represents the mean (t-test). (C) Hepatocellular ER stress as 
assessed by immunofluorescent staining for BiP in IL-22-/- and WT mice before and 
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48h post partial hepatectomy. (D) Quantification of immunofluorescence revealed 
elevated expression of BIP/GRP78 IL-22-/- mice post liver resection at 48h. (E) 
Analysis of Phospho-eIF2α (P-eIF2α) as a downstream protein by western blotting. 
Expression of Phospho-eIF2α is higher at base line (0h) and increased at 6h and 24h 
post liver resection in IL-22-/- mice compared to WT mice.   
 
Figure 4. IL-22 is secreted by subsets of innate lymphoid cells in humans and 
mice. IL-22 secretion was assessed by FACS (A) and ELISA (B) in different cellular 
subsets from human hepatic lymphocytes (n=5, t-test). Main producers of IL-22 are 
CD56dimCD3- NK cells. (C, D) Levels of IL-22 and liver injury was assessed 48h after 
partial hepatectomy in WT, Rag1-/- (lacking T, and B cells) and Rag2-/-γc-/-  (lacking T, 
B, cNK and innate lymphoid cells) mice (n=5-6, t-test). (D) Lack of cNK cells and ILC 
is associated with significantly increased liver injury (n=5, each data point represents 
a single mouse, the line indicates the mean, t-test). (E) Analysis of rodent liver 
resident CD49a+NK1.1+CD3- (ILC1) and CD49b+NK1.1+CD3- (cNK) cell fractions pre 
and post partial hepatectomy (n=3, t-test).  
 
Figure 5. Elevated levels of extracellular ATP in patients post liver resection. 
(A) Extracellular ATP was assessed using luciferin luciferase assay in samples of 27 
patients that underwent major liver resection in different venous compartments. Each 
data point represents a single patient. ATP levels were significantly elevated post 
liver resection compared to pre-operative levels. (B) Samples were dichotomized 
based on the presence of post hepatectomy liver failure according to the international 
Study Group of Liver Surgery (ISGLS) score. Levels of extracellular ATP were 
significantly lower in the hepatic vein in patients with post hepatectomy liver failure 
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compared to patients without liver failure (each data point represents a single patient; 
line represents the mean, t-test). 
 
Figure 6. Dysregulated purinergic signaling results in abrogated IL-22 secretion 
(A) Hepatic infiltrating lymphocytes and splenocytes from WT mice were stimulated 
using anti-CD3, anti-CD28, IL-12, IL-18 and IL-23. Incubation with the unspecific P2 
receptor antagonist suramin is associated with significantly decreased IL-22 secretion 
(n=3, t-test). Screening was performed using various P1 and P2 receptor agonists 
and antagonists. (B) Activation of adenosine receptors in splenocytes is not 
associated with altered IL-22 secretion. (C) Antagonism of P2X1 (NF449) or P2Y6 
(MRS2578) using specific inhibitors was associated with a significant and (D) dose 
dependent reduction of IL-22 secretion in human hepatic lymphocytes. (E) 
Disordered purinergic signaling in response to deletion of NTPDase1/CD39 (major 
ectonucleotidase) is associated with significantly reduced IL-22 secretion in isolated 
liver lymphocytes in vitro and (F) in vivo post partial hepatectomy in CD39-/- mice 
compared to WT mice. Liver injury in CD39-/- mice is significantly increased 
compared to WT mice. 
 
Figure 7. Inhibition of P2X1 is associated with decreased secretion of IL-22 and 
impaired liver regeneration in vivo. WT mice were injected with PBS or with P2X1 
(NF449) or P2Y6 (MRS2578) antagonists 1 hour prior liver resection. (A, B) Inhibition 
of P2X1 via NF449 is associated with significant reduction of IL-22 levels 24 hours 
post liver resection whereas P2Y6 inhibition is only associated with IL-22 reduction at 
very high levels. (C-E) Liver regeneration as assessed by Ki67 and PCNA staining is 
not altered in response to P2Y6 (MRS2578) inhibition whereas it is significantly 
decreased in response to P2X1 (NF449) inhibition. (F) Significant elevation of liver 
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injury in response to P2X1 (NF449) antagonism but not in response to P2Y6 
(MRS2578 (50µg)) antagonism in vivo (n=5, mean, standard deviation, t-test). 
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Supplementary figure 1 
(A) Levels of IL-22 patients (n=18) before and after major pancreatic surgery. No 
elevation of IL-22 levels was observed. Each data point represents an individual 
patient, the line represents the mean.  
 
Supplementary figure 2 
(A) Body and liver weights from WT and IL-22-/- mice were measured at 0h, 48h, and 
120h post liver resection. Liver to body weight ratio was significantly decreased in IL-
22-/- compared to WT mice at 48h post liver resection. (B) Expression of IL-22 
receptor in WT mice was assessed at different time points post liver resection by 
qPCR and compared to naïve mice (n=5 per time point) (mean±SD, t-test). (C)  
Expression of IL-22 receptor in human resected liver tissue was assessed by RT-
PCR. (D) Hematoxylin and Eosin (H&E) staining in liver tissue section in WT and IL-
22-/-  mice 48h post liver resection (n=5 mice). Increased hepatocellular injury and 
focal liver necrosis occurred in IL-22-/- mice.  
 
Supplementary figure 3  
Lymphocyte subsets from the liver (B) and spleen (C) of WT mice were FACS sorted 
and stimulated for 24 hours with α-CD3, α-CD28,  IL-23, IL-12  and IL-18 ex vivo, 
supernatants were analyzed for IL-22 concentrations using ELISA. This experiment 
was done at least 3 times with three replicates/each time (mean±SD).  
  
Supplementary figure 4  
(A) Serum levels of IL-22 were assessed in samples taken 24 hours post partial 
hepatectomy from WT, Rag1-/- and Rag2-/-γc-/- mice using ELISA (n=5, mean±SD, t-
test). (B) ILC fractions of hepatic lymphocytes of untreated WT and Rag1-/- mice (n=5 
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mice, mean±SD). In Rag1-/- mice, fractions of ILC1 (CD49+NK1.1+CD3-),  and cNK 
(CD49b+NK1.1+CD3-) are increased when compared to WT mice. (C) Liver injury 24 
hours post liver resection in WT mice, Rag1-/- and Rag2-/-γc-/- mice as measured by 
ALT (at least two individual experiments (5 animals/experiment, mean±SD, t-test)). 
(D) H and E staining was done in liver tissues obtained 24h post hepatectomy from 
WT mice, Rag1-/- and Rag2-/-γc-/- mice (representative of 5 mice per group).   
 
Supplementary figure 5 
(A) Hepatic liver lymphocytes were isolated and analyzed for various subsets of ILC 
(ILC1, ILC2, ILC3 and cNK cells) by FACS. The predominant populations in the 
mouse liver are ILC1 and cNK whereas ILC2 and ILC3 represent only minor fractions 
(representative of at least 3 experiments).  
 
Supplementary figure 6 
(A) Expression analysis retrieved from GEO database (GEO accession number 
GSE43339) of purinergic P2X and P2Y receptors in isolated hepatic lymphocytes. (B) 
Liver lymphocytes and splenocytes from WT and IL-22-/- mice were isolated 
stimulated with α-CD3, α-CD28, IL-23, IL-12 and IL-18 ex vivo and supernatants 
were further analyzed using ELISA. Each figure represents at least three individual 
experiments (mean±SEM, t-test).  
 
Supplementary figure 7 
Splenocytes from WT mice were isolated and stimulated with α-CD3, α-CD28, IL-23, 
IL-12 and IL-18 ex vivo with (A) broad adenosine agonists and specific inhibition of 
adenosine receptor (B) A1 by DPCPX and (C) A2A by ZM241385 for 24 hours. 
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Supernatants were further analyzed using ELISA. Each figure represents at least 
three individual experiments (mean±SEM, t-test). 
Supplementary figure 8 
Expression of CD39 on lymphocytes: (A) Hepatic infiltrating lymphocytes from WT 
mice and CD39-/- mice were isolated and analyzed by FACS. Expression of CD39 on 
NK, T cell subsets (CD4+ T Cells, CD8+T cells and Gamma Delta T cells) and B 
cells. All the data in the figure represent at least 3 individual experiments.  
Impact of CD39 on IL-22 secretion: (B) Hepatic infiltrating lymphocytes from WT mice 
were isolated and stimulated with IL-23 (10ng/ml) and with Brefeldin (10µg/ml) ex 
vivo for 5 hours and were further analyzed by FACS and reveal the expression of 
CD39 on IL-22 positive cells in the stimulated samples. Representative values in 
FACS plot are an average from 3 individual experiments (t-test). (C) Splenic 
lymphocytes from WT and CD39 null mice were isolated and stimulated with IL-23, 
IL-12 and IL-18 ex vivo and supernatants were further analyzed using ELISA.  
Impact of CD39 on IL-22 secretion of various subsets of lymphocytes: (D, E) Liver 
lymphocytes from WT mice and CD39 null mice were isolated and stimulated with IL-
23 (10ng/ml) and with Brefeldin (10µg/ml) in ex vivo for 5 hours and were further 
analyzed by FACS. Representative FACS plots show the decreased expression of IL-
22 overall and also in individual cells subsets (cNK cells) in CD39 null mice 
compared to WT mice (3 individual experiments, t-test).  
 
Supplementary figure 9 
(A) Liver injury after different time points (6h, 24h and 48h) post liver resection in WT 
mice and CD39 null mice as assessed by ALT. Liver injury is increased in CD39 null 
mice at 24h and 48h post liver resection (n=5, mean±SEM, t-test). (B) H and E 
staining of liver tissues obtained from WT mice, CD39-/- mice and WT mice injected 
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either with P2X1 antagonist (NF449) or with P2Y6 antagonist (MRS2578) 48h post 
hepatectomy (n=5 mice).   
 
Supplementary figure 10 
(A) Analysis of expression of P2X1 receptor of FACS sorted liver lymphocytes by RT-
PCR. P2X1 is expressed in NK, ILC1, NKT, CD4, CD8 and gamma delta T cells. This 
experiment was repeated at least three times and genomic DNA contamination was 
ruled out by running negative reverse transcription. (B) WT mice were injected with 
saline or with NF449 a P2X1 antagonist one hour prior liver resection. In mice 
injected with NF449, liver injury as assessed by ALT is significantly increased 48 
hours post partial liver resection (n=5, mean± SEM, t-test). (C) WT mice were 
injected with DMSO or with MRS2578 a P2Y6 antagonist one hour prior liver 
resection. No difference in liver injury was observed (n=5, mean± SEM, t-test). 
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P2X1 regulated IL-22 secretion by innate lymphoid cells is required for 
efficient liver regeneration 
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 2 
Supplementary table 1 
Patient Characteristics (n=40) 
Variable  
Age, yr, mean (SD) 64 (12) 
Cases with extended resection, n 12 (30%) 
Surgery for Hepatocellular Carcinoma, n 13 (32.5%) 
Surgery for Cholangiocellular Carcinoma, n 11 (27.5%) 
Surgery for Metastasis, n 14 (35%) 
Surgery for Benign Lesions, n 2 (5%) 
Cases with complications, n 26 (65%) 
Cases with severe complications, n 14 (35%) 
Cases with Posthepatectomy Liver Failure 8 (20%) 
 
Major resection: ≥3 segments, Extended resection: ≥5 segments, Severe 
complications: ≥ Grade 3 according Clavien-Dindo classification, 
Posthepatectomy Liver Failure: definition according ISGLS criteria 
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Supplementary table 2 
Patient’s characteristics  
Variable No PHLF 
(n = 22) 
PHLF 
(n = 5) 
Age, yr, mean (SD) 55 (12) 60 (13) 
Units RBCs intraoperatively, 
mean (SD) 
0.1 (0.4) 0 (0) 
Length of ICU stay, days, mean 
(SD) 
1.3 (1.1) 4 (6) 
Length of hospital stay, days, 
mean (SD) 
10.3 (7.1) 18 (19) 
Cases with complications, n 8 (36%) 4 (80%) 
Cases with severe 
complications, n 
2 (9%) 1 (20%) 
 
PHLF: Posthepatectomy Liver Failure (according ISGLS criteria), Major 
resection: ≥3 segments, Severe complications: ≥ Grade 3 according Clavien-
Dindo classification  
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